Common use
Medroxyprogesterone is a synthetic progestin — a laboratory-produced form of the naturally occurring hormone progesterone — widely used to treat a range of gynecological and hormonal conditions. As a trusted Provera generic, medroxyprogesterone is commonly prescribed for menstrual disorders, including irregular periods, abnormal uterine bleeding, and amenorrhea (the absence of menstruation). It plays an important role in hormone therapy for menopausal women, where it is combined with estrogen to protect the uterine lining from the overgrowth (endometrial hyperplasia) that estrogen-only therapy can cause, thereby reducing the risk of endometrial cancer. In its injectable depot formulation, medroxyprogesterone is one of the most widely used long-acting contraceptive methods worldwide, providing reliable birth control protection for three months per injection. The medication works by mimicking the effects of natural progesterone — regulating the menstrual cycle, stabilizing the endometrial lining, and suppressing ovulation when used for contraception. Medroxyprogesterone may also be prescribed as part of adjunctive treatment for certain hormone-sensitive conditions including endometriosis and select cases of endometrial cancer.

Dosage and direction
Medroxyprogesterone is available in both oral tablet and injectable formulations, with the route and dose depending on the specific condition being treated. For menstrual disorder management such as abnormal bleeding or amenorrhea, the oral tablet is typically prescribed at 5 to 10 mg once daily for 5 to 10 days during a specific phase of the menstrual cycle, as directed by your physician. For hormone therapy in combination with estrogen during menopause, the usual oral dose is 2.5 mg daily (continuous regimen) or 5 to 10 mg daily for 12 to 14 days of each month (cyclic regimen). For long-term contraception, the intramuscular depot injection (150 mg) is administered by a healthcare professional every 12 to 13 weeks (approximately every three months), and the subcutaneous version (104 mg) follows a similar schedule. Dosage and treatment duration vary significantly depending on the individual patient's medical condition, treatment goals, and clinical response, so all adjustments should be made exclusively by your prescribing healthcare provider.

Precautions
Before starting medroxyprogesterone, inform your doctor of any personal or family history of blood clots (deep vein thrombosis or pulmonary embolism), breast cancer, liver disease, stroke, or heart disease, as these conditions may significantly affect the safety of progestin therapy. This medication may cause fluid retention, so it should be used cautiously in patients with cardiovascular disease, renal impairment, epilepsy, migraines, or asthma, where fluid accumulation could worsen symptoms. Cigarette smoking while using hormonal medications like medroxyprogesterone increases the risk of serious cardiovascular side effects, including blood clots, stroke, and heart attack — this risk is especially elevated in women over 35 years of age. Regular medical monitoring is strongly recommended during long-term use, including periodic breast examinations, pelvic examinations, and blood pressure checks. Women using the injectable form for contraception should be counseled about the potential for reduced bone mineral density with prolonged use, and calcium and vitamin D supplementation may be recommended. Report any unusual symptoms such as severe headaches, visual disturbances, chest pain, or leg swelling to your doctor immediately.

Contraindications
Medroxyprogesterone is contraindicated in patients with active or recent thrombophlebitis, thromboembolic disease, or cerebrovascular disease. It should not be used in individuals with significant liver dysfunction or active liver disease, as impaired hepatic metabolism can lead to dangerously elevated hormone levels. Undiagnosed abnormal vaginal bleeding is an absolute contraindication — the cause of bleeding must be fully evaluated and treated before initiating progestin therapy. Known or suspected breast cancer, genital cancer, or other hormone-dependent neoplasms represent strict contraindications for this Provera generic. Medroxyprogesterone should not be used during pregnancy unless specifically prescribed for a documented medical indication such as threatened miscarriage, and a pregnancy test should be performed before starting treatment. Individuals with a known hypersensitivity to medroxyprogesterone acetate or any excipient in the formulation should avoid use. The injectable depot form is generally not recommended for adolescents who have not yet achieved peak bone mass, due to concerns about potential bone mineral density loss that may not be fully reversible.

Possible side effect
Common side effects of medroxyprogesterone include weight changes (both gain and loss), abdominal bloating, breast tenderness or swelling, and menstrual irregularities such as breakthrough bleeding, spotting, or changes in menstrual flow. Some patients may experience headaches, mood changes including depression or irritability, acne, or increased facial hair growth. Fatigue, decreased libido, and mild fluid retention are also reported. Serious side effects that require immediate medical attention include blood clots presenting as sudden leg pain or swelling (deep vein thrombosis), chest pain or shortness of breath (pulmonary embolism), sudden severe headache or vision disturbances (possible stroke), and signs of allergic reaction such as hives, facial swelling, or difficulty breathing. Prolonged use of the injectable form has been associated with decreased bone mineral density, which may increase the risk of osteoporotic fractures later in life. Seek immediate medical help if any of these serious symptoms occur during your hormone therapy.

Drug interaction
Medroxyprogesterone may interact with medications that induce hepatic cytochrome P450 enzymes, including rifampin, phenytoin, carbamazepine, and phenobarbital, which can accelerate the metabolism of the progestin and potentially reduce its effectiveness for both menstrual disorder treatment and contraception. Herbal supplements, particularly St. John's Wort, are known to reduce the blood levels of hormonal medications and may compromise contraceptive reliability. Medroxyprogesterone may also influence the metabolism of other hormonal therapies, including estrogen-containing products and thyroid medications, potentially altering their effectiveness. Certain protease inhibitors used in HIV treatment and some antifungal medications may also interact with this Provera generic. Always provide your doctor and pharmacist with a comprehensive list of all prescription medications, over-the-counter drugs, vitamins, and herbal supplements you are currently taking before starting medroxyprogesterone therapy.

Missed dose
If an oral tablet dose of medroxyprogesterone is missed, take it as soon as you remember, unless it is close to the time of the next scheduled dose — in that case, skip the missed dose and continue with your regular schedule. Do not take a double dose to compensate. If you miss an injectable depot appointment for birth control, contact your healthcare provider immediately, as backup contraception (such as condoms) may be necessary until the injection can be administered and full protection is re-established. Consistency in dosing is critically important for the effectiveness of hormone therapy, menstrual regulation, and contraceptive protection. If you frequently miss oral doses, discuss alternative formulations or dosing reminders with your doctor.

Overdose
Symptoms of medroxyprogesterone overdose may include nausea, vomiting, dizziness, drowsiness, or unexpected vaginal bleeding. While acute overdose of progestin medications is generally not considered life-threatening, medical evaluation is still necessary to rule out complications and ensure patient safety. There is no specific antidote for medroxyprogesterone overdose, and treatment is symptomatic and supportive. Seek immediate medical attention if overdose is suspected, particularly if large quantities have been ingested or if the patient is experiencing severe or persistent symptoms.

Storage
Store medroxyprogesterone oral tablets at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from moisture, heat, and direct sunlight. Injectable depot formulations should be stored according to the manufacturer's package instructions, typically between 15°C and 30°C (59°F to 86°F) — do not freeze the injectable product. Keep all forms of the medication out of reach of children and pets. Do not use medroxyprogesterone after the expiration date printed on the packaging, and dispose of unused or expired medication properly according to local pharmaceutical regulations.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.